Hypha Labs, Inc.
FUNI
$0.029
-$0.001-3.33%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 1,116.28% | 522.26% | 29.58% | -46.01% | -85.60% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 1,116.28% | 522.26% | 29.58% | -46.01% | -85.60% |
Operating Income | -1,116.28% | -522.26% | -29.58% | 46.01% | 85.60% |
Income Before Tax | -337.65% | -93.14% | 27.51% | 74.10% | 71.53% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -340.08% | -95.16% | 25.70% | 71.41% | 71.53% |
Earnings from Discontinued Operations | -76.07% | -38.35% | 68.93% | 1,349.01% | 3,855.99% |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -456.46% | -418.27% | 93.08% | 154.97% | 131.62% |
EBIT | -1,116.28% | -522.26% | -29.58% | 46.01% | 85.60% |
EBITDA | -6,283.38% | -918.63% | 26.59% | 97.32% | 97.52% |
EPS Basic | -352.70% | -321.43% | 106.25% | 148.21% | 127.82% |
Normalized Basic EPS | -314.29% | -145.83% | 8.04% | 46.90% | 74.70% |
EPS Diluted | -398.65% | -442.86% | 75.89% | 142.52% | 125.00% |
Normalized Diluted EPS | -314.29% | -145.83% | 8.04% | 46.90% | 74.70% |
Average Basic Shares Outstanding | 30.07% | 20.79% | 15.54% | 11.29% | 11.10% |
Average Diluted Shares Outstanding | 30.07% | 20.79% | 15.54% | 11.29% | 11.10% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |